{"entity":{"type":"insider","cik":"0001346974","url":"/insider/0001346974","json_url":"/insider/0001346974.json","name":"Abate Thomas M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":38,"n_filings":19,"first":"2010-02-25","last":"2013-05-09","span_basis":"filed_date"},"name_variants":[{"name":"Abate Thomas M","source":"filing","n_filings":19,"first_seen":"2010-02-25","last_seen":"2013-05-09"}],"transactions":[{"id":5255558,"accession":"0001225208-13-011895","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-13-011895","line_url":"/filing/0001225208-13-011895#line-3","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":63.75,"price_display":"63.75","price_state":"stated","total_value":956250.0,"total_display":"956,250.00","total_whole":"956,250","shares_owned_after":44393.0,"shares_owned_after_display":"44,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-07","filed_date":"2013-05-09","scope":"insider"},{"id":4875938,"accession":"0001225208-13-010469","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-13-010469","line_url":"/filing/0001225208-13-010469","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":64.524,"price_display":"64.52","price_state":"stated","total_value":645240.0,"total_display":"645,240.00","total_whole":"645,240","shares_owned_after":46688.9764,"shares_owned_after_display":"46,688.98","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-26","filed_date":"2013-04-26","scope":"insider","n_lines":2},{"id":5485875,"accession":"0001225208-13-004558","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-13-004558","line_url":"/filing/0001225208-13-004558#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":86.38,"price_display":"86.38","price_state":"stated","total_value":1036560.0,"total_display":"1,036,560.00","total_whole":"1,036,560","shares_owned_after":46474.0,"shares_owned_after_display":"46,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-14","filed_date":"2013-02-19","scope":"insider"},{"id":5080961,"accession":"0001225208-13-003628","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001225208-13-003628","line_url":"/filing/0001225208-13-003628","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11826.0,"shares_display":"11,826","price_per_share":85.61471334348046,"price_display":"85.61","price_state":"stated","total_value":1012479.6,"total_display":"1,012,479.60","total_whole":"1,012,480","shares_owned_after":46474.0,"shares_owned_after_display":"46,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-07","filed_date":"2013-02-11","scope":"insider","n_lines":3},{"id":2302507,"accession":"0001225208-12-018674","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-12-018674","line_url":"/filing/0001225208-12-018674","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":99.136417,"price_display":"99.14","price_state":"stated","total_value":1982728.34,"total_display":"1,982,728.34","total_whole":"1,982,728","shares_owned_after":46474.0,"shares_owned_after_display":"46,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-24","filed_date":"2012-08-28","scope":"insider","n_lines":2},{"id":3499581,"accession":"0001225208-12-016839","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001225208-12-016839","line_url":"/filing/0001225208-12-016839","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":104.8904,"price_display":"104.89","price_state":"stated","total_value":1573356.0,"total_display":"1,573,356.00","total_whole":"1,573,356","shares_owned_after":46474.0,"shares_owned_after_display":"46,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-27","filed_date":"2012-07-30","scope":"insider","n_lines":3},{"id":3499573,"accession":"0001225208-12-016839","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001225208-12-016839","line_url":"/filing/0001225208-12-016839","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":102.35503888888888,"price_display":"102.36","price_state":"stated","total_value":4605976.75,"total_display":"4,605,976.75","total_whole":"4,605,977","shares_owned_after":46474.0,"shares_owned_after_display":"46,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-26","filed_date":"2012-07-30","scope":"insider","n_lines":4},{"id":3400728,"accession":"0001225208-12-015065","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-12-015065","line_url":"/filing/0001225208-12-015065","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":103.00626666666666,"price_display":"103.01","price_state":"stated","total_value":1545094.0,"total_display":"1,545,094.00","total_whole":"1,545,094","shares_owned_after":46366.0,"shares_owned_after_display":"46,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-29","filed_date":"2012-06-29","scope":"insider","n_lines":2},{"id":2500786,"accession":"0001225208-12-011152","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001225208-12-011152","line_url":"/filing/0001225208-12-011152","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":84.1954,"price_display":"84.20","price_state":"stated","total_value":841954.0,"total_display":"841,954.00","total_whole":"841,954","shares_owned_after":47902.0,"shares_owned_after_display":"47,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-01","filed_date":"2012-05-03","scope":"insider","n_lines":3},{"id":2076594,"accession":"0001225208-12-010387","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-12-010387","line_url":"/filing/0001225208-12-010387","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":81.466247,"price_display":"81.47","price_state":"stated","total_value":814662.47,"total_display":"814,662.47","total_whole":"814,662","shares_owned_after":47902.0,"shares_owned_after_display":"47,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-04-26","filed_date":"2012-04-27","scope":"insider","n_lines":2},{"id":3195126,"accession":"0001225208-12-008522","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-12-008522","line_url":"/filing/0001225208-12-008522#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":72.8,"price_display":"72.80","price_state":"stated","total_value":728000.0,"total_display":"728,000.00","total_whole":"728,000","shares_owned_after":47625.0,"shares_owned_after_display":"47,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-29","filed_date":"2012-03-30","scope":"insider"},{"id":2574621,"accession":"0001225208-12-007699","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001225208-12-007699","line_url":"/filing/0001225208-12-007699","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":69.8444,"price_display":"69.84","price_state":"stated","total_value":698444.0,"total_display":"698,444.00","total_whole":"698,444","shares_owned_after":47625.0,"shares_owned_after_display":"47,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-15","filed_date":"2012-03-15","scope":"insider","n_lines":2},{"id":2447528,"accession":"0001225208-12-005288","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-12-005288","line_url":"/filing/0001225208-12-005288#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":74.12,"price_display":"74.12","price_state":"stated","total_value":741200.0,"total_display":"741,200.00","total_whole":"741,200","shares_owned_after":47925.0,"shares_owned_after_display":"47,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-23","filed_date":"2012-02-23","scope":"insider"},{"id":3373654,"accession":"0001225208-12-003757","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-12-003757","line_url":"/filing/0001225208-12-003757#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":73.42,"price_display":"73.42","price_state":"stated","total_value":734200.0,"total_display":"734,200.00","total_whole":"734,200","shares_owned_after":47925.0,"shares_owned_after_display":"47,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-09","filed_date":"2012-02-10","scope":"insider"},{"id":3416540,"accession":"0001225208-12-001302","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-12-001302","line_url":"/filing/0001225208-12-001302#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":73.91,"price_display":"73.91","price_state":"stated","total_value":739100.0,"total_display":"739,100.00","total_whole":"739,100","shares_owned_after":47925.0,"shares_owned_after_display":"47,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-12","filed_date":"2012-01-12","scope":"insider"},{"id":2499197,"accession":"0001225208-12-000156","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001225208-12-000156","line_url":"/filing/0001225208-12-000156","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11332.0,"shares_display":"11,332","price_per_share":71.10039887045535,"price_display":"71.10","price_state":"stated","total_value":805709.72,"total_display":"805,709.72","total_whole":"805,710","shares_owned_after":47925.0,"shares_owned_after_display":"47,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-29","filed_date":"2012-01-03","scope":"insider","n_lines":2},{"id":8968366,"accession":"0001225208-11-021222","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001225208-11-021222","line_url":"/filing/0001225208-11-021222#line-4","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7929.0,"shares_display":"7,929","price_per_share":75.16,"price_display":"75.16","price_state":"stated","total_value":595943.64,"total_display":"595,943.64","total_whole":"595,944","shares_owned_after":47925.0,"shares_owned_after_display":"47,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-31","filed_date":"2011-09-01","scope":"insider"},{"id":8968364,"accession":"0001225208-11-021222","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-11-021222","line_url":"/filing/0001225208-11-021222#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7966.0,"shares_display":"7,966","price_per_share":73.72,"price_display":"73.72","price_state":"stated","total_value":587253.52,"total_display":"587,253.52","total_whole":"587,254","shares_owned_after":47925.0,"shares_owned_after_display":"47,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-30","filed_date":"2011-09-01","scope":"insider"},{"id":9183475,"accession":"0001225208-11-013882","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-11-013882","line_url":"/filing/0001225208-11-013882#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2668.0,"shares_display":"2,668","price_per_share":88.07,"price_display":"88.07","price_state":"stated","total_value":234970.76,"total_display":"234,970.76","total_whole":"234,971","shares_owned_after":44350.0,"shares_owned_after_display":"44,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-10","filed_date":"2011-05-10","scope":"insider"},{"id":9183474,"accession":"0001225208-11-013882","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-11-013882","line_url":"/filing/0001225208-11-013882#line-1","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO)","role_mark":"O","role_mark_label":"Officer (CVP, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2185.0,"shares_display":"2,185","price_per_share":88.2,"price_display":"88.20","price_state":"stated","total_value":192717.0,"total_display":"192,717.00","total_whole":"192,717","shares_owned_after":47018.0,"shares_owned_after_display":"47,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-10","scope":"insider"},{"id":7735247,"accession":"0001225208-10-025548","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001225208-10-025548","line_url":"/filing/0001225208-10-025548#line-5","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CVP, CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":65.68,"price_display":"65.68","price_state":"stated","total_value":394080.0,"total_display":"394,080.00","total_whole":"394,080","shares_owned_after":49154.0,"shares_owned_after_display":"49,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-23","filed_date":"2010-11-23","scope":"insider"},{"id":7735245,"accession":"0001225208-10-025548","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001225208-10-025548","line_url":"/filing/0001225208-10-025548#line-4","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CVP, CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33622.0,"shares_display":"33,622","price_per_share":66.85,"price_display":"66.85","price_state":"stated","total_value":2247630.7,"total_display":"2,247,630.70","total_whole":"2,247,631","shares_owned_after":55154.0,"shares_owned_after_display":"55,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-22","filed_date":"2010-11-23","scope":"insider"},{"id":7434353,"accession":"0001225208-10-005839","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-10-005839","line_url":"/filing/0001225208-10-005839#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001346974","owner_name":"Abate Thomas M","owner_display_name":"Abate Thomas M","owner_url":"/insider/0001346974","role":"Officer (CVP, CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CVP, CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":90.24,"price_display":"90.24","price_state":"stated","total_value":4512000.0,"total_display":"4,512,000.00","total_whole":"4,512,000","shares_owned_after":27584.0,"shares_owned_after_display":"27,584","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-23","filed_date":"2010-02-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":38,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":38,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":38},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001099800","name":"Edwards Lifesciences Corp","url":"/issuer/0001099800","role":"Officer (CVP, CFO)","n_filings":19,"first_seen":"2010-02-25","last_seen":"2013-05-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001346974","retrieved_at":"2026-08-25T15:12:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}